## MAR: Marriott International, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 2.9% below STRENGTH zone (4.0-10.0%); PEG 1.70 fails VALUE criteria (<1.0); RSI 73 overbought. Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.5% MRS), overbought RSI (73).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($293.81)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. How Is Marriott International’s Stock Performance Compared to Other Hotel Stocks?**
- Source: MSN | 20251202T220914 | Neutral | Relevance: 100%
- This article will compare Marriott International's stock performance to other major hotel stocks. It will likely include an analysis of its financial metrics and market position against competitors in the hospitality industry. The comparison aims to provide insights into Marriott's relative strength or weakness in the stock market.

**2. NoMad Las Vegas now Reserve at Park MGM**
- Source: HOTELSMag.com | 20251201T172150 | Somewhat-Bullish | Relevance: 84%
- MGM Resorts International announced that NoMad Las Vegas will transition to The Reserve at Park MGM on December 17, operating with 293 rooms and suites. This rebranding includes renaming several venues like NoMad Pool to The Terrace Pool and NoMad Bar to The Reserve Bar. The Reserve at Park MGM is also expected to join Marriott Bonvoy’s Autograph Collection in early 2026 as part of MGM Resorts’ strategic partnership with Marriott International.

**3. NoMad Las Vegas to rebrand as The Reserve at Park MGM**
- Source: Investing.com Australia | 20251202T014400 | Neutral | Relevance: 75%
- MGM Resorts International announced the rebranding of NoMad Las Vegas as The Reserve at Park MGM, effective December 17, with plans for it to join Marriott Bonvoy’s Autograph Collection in early 2026. This move expands MGM's strategic partnership with Marriott and allows Marriott Bonvoy members to earn and redeem points at the property, adding to the 13 destinations on the Las Vegas Strip under the MGM Collection with Marriott Bonvoy. The rebranding occurs amidst recent analyst downgrades for MGM Resorts due to weaker-than-expected Las Vegas operations and increasing capital outflows.

**4. Agilysys InfoGenesis® (POS) Platform Approved by IHG Hotels & Resorts Across Its Portfolio**
- Source: Hotel Online | 20251203T052247 | Somewhat-Bullish | Relevance: 74%
- Agilysys InfoGenesis, a cloud-native POS platform, has been approved for use across IHG Hotels & Resorts' portfolio, becoming a global POS provider for all hotel segments. This partnership aims to enhance operational efficiency and guest experience by offering a comprehensive, omnichannel platform that integrates with IHG's property management systems. The InfoGenesis ecosystem provides versatile solutions for food-and-beverage, retail, and various service areas, supporting mobile transactions and self-service ordering.

**5. NoMad Las Vegas Set to Rebrand into The Reserve at Park MGM**
- Source: Luxury Travel Advisor | 20251203T090849 | Somewhat-Bullish | Relevance: 74%
- MGM Resorts International announced that NoMad Las Vegas will rebrand as The Reserve at Park MGM, with the transition completing on December 17. The 293-room property will offer a sophisticated experience, with several venues also receiving new names. In early 2026, The Reserve at Park MGM is expected to join Marriott Bonvoy’s Autograph Collection, allowing Marriott Bonvoy members to book stays and earn/redeem points.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-18 | Wells Fargo | $329 | $0 | 0% |
| 2025-11-05 | Barclays | $274 | $262 | +5% |
| 2025-11-05 | BMO Capital | $285 | $280 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-18 | Wells Fargo | init | Overweight |
| 2025-11-05 | Barclays | main | Equal-Weight |
| 2025-11-05 | BMO Capital | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.00M) |
| Sells | 14 ($27.11M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 7.7% (+1.1%)
- Blackrock Inc.: 5.7% (+0.3%)
- JPMORGAN CHASE & CO: 5.0% (+40.6%)
- State Street Corpora: 3.5% (-0.3%)
- Wellington Managemen: 3.4% (+21.7%)

### Key Risks

1. Heavy insider selling: $27M sold (14 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.70 elevated, pricing in significant growth expectations. Forward P/E 27.0x stretched relative to 12% growth. Quality metrics strong (margin 38%). Insider selling cluster ($27.1M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $85.7B |
| Beta | 1.16 |
| 52W Range | $205.40 - $316.69 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.70 |
| Forward P/E | 27.0 |
| Current P/E | 30.3 |
| YoY Growth | 12.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 6.4% to 2.9% (-3.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.1pp (needs >4.0% for momentum thesis). MRS_5 at 0.1% confirms short-term momentum alignment. AM_20 at 4.9% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.20), confirming momentum. RSI overbought at 73, risk of mean reversion. OFD pattern: +MUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.93% (CS: 77) | Neutral |
| RSI_14 | 73.1 | Overbought |
| MACD Histogram | 1.20 | Bullish |
| vs SMA20 | 1.047x | Above |
| vs SMA50 | 1.110x | Above |
| vs SMA200 | 1.163x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $306.65
- **Stop Loss:** $293.81 (4.2% risk)
- **Target:** $319.49 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 88
- **Position Value:** $26,985.20
- **Portfolio %:** 26.99%
- **Risk Dollars:** $1,140.00
- **Risk Per Trade:** 1.14%
- **Modifiers:** L1 95% | L2 120% | Combined 1.14x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-10 (Est: $2.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.39 | $2.47 | +3.5% |
| 2025Q2 | $2.62 | $2.65 | +1.1% |
| 2025Q1 | $2.25 | $2.32 | +3.0% |
| 2024Q4 | $2.38 | $2.45 | +2.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*